Saturday, February 07, 2026 | 10:13 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Emcure Pharmaceuticals Share Price

Know More
BSENSE

1,515.95 32.50 (2.19%)

6-Feb-2026

1,515.70 33.40 (2.25%)

6-Feb-2026

BSE : 544210

NSE : EMCURE

Sector : Health care

ISIN Code : INE168P01015

  • BSE
  • NSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: 06-Feb-2026 | 05:30 AM IST

Market Cap (₹ Cr.)

28,738

Traded Value (₹ Cr)

0.79

Volume (Shares)

5,211

Face Value (₹)

10

52-Week High (₹)

1,585.50

52-Week High Date

19-Jan-2026

52-Week Low (₹)

890.00

52-Week Low Date

07-Apr-2025

All Time High (₹)

1,585.50

All Time High Date

19-Jan-2026

All Time Low (₹)

890.00

All Time Low Date

07-Apr-2025

Emcure Pharmaceuticals Ltd

Emcure Pharmaceuticals Limited was originally incorporated as `Emcure Pharmaceuticals Private Limited' as a Private Company pursuant to a Certificate of Incorporation dated April 16 1981 issued by Registrar of Companies Maharashtra at Bombay. Subsequently Company was converted into a Public Company and the name of Company was changed to `Emcure Pha...
Read More
BSE
NSE

Emcure Pharmaceuticals Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr.)

28,733

EPS - TTM (₹) [C]

47.20

P/E Ratio (X) [C]

32.11

Face Value (₹) 10
Latest Dividend (%)30.00
Latest Dividend Date 14-Aug-2025
Dividend Yield (%) 0.20
Book Value Share (₹) [C]250.17
P/B Ratio (₹) [C]6.06

Funds Owning this Stock

Scheme Name Amount Invested (₹ Cr) No Of Shares Net Asset (%)
UTI-Healthcare Fund (IDCW) 10.98 75,000 1.04
UTI-Healthcare Fund (G) 10.98 75,000 1.04
UTI-Healthcare Fund - Direct (G) 10.98 75,000 1.04
UTI-Healthcare Fund - Direct (IDCW) 10.98 75,000 1.04

Research Reports

DateBrokerActionPrices(₹) Report
24-Nov-2025JM Financial Buy 1,695

Stock Strength

Today's Low/High (₹)

1,461.10

1,520.00

Week Low/High (₹)

1,422.20

1,554.00

Month Low/High (₹)

1,410.00

1,586.00

Year Low/High (₹)

889.00

1,586.00

All time Low/High (₹)

890.00

1,586.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week3.50%3.55%1.59%1.47%
1 Month-0.71%-0.80%-1.74%-1.85%
3 Month14.36%14.42%0.15%0.38%
6 Month6.65%6.57%3.77%4.56%
1 Year17.86%17.93%7.07%8.86%
3 Year--38.13%44.63%

Company Info

Company Information

Whole Time Director : MUKUND KESHAO GURJAR

Whole Time Director : SUNIL RAJNIKANT MEHTA

Managing Director & Chief Executive Officer : SATISH RAMANLAL MEHTA

Chairman (Non-Executive) : Berjis M Desai

Whole Time Director : NAMITA VIKAS THAPAR

Independent Director : P S Jayakumar

Independent Director : Vijay Gokhale

Independent Director : Vidya Rajiv Yeravdekar

Independent Director : Shailesh Ayyangar

Whole-time Director : SAMIT SATISH MEHTA

Registered Office: Plot # P-1 & P-2 IT BT Park, Phase II MIDC Hinjawadi,Pune,Maharashtra-411057 Ph: +91 20 3507 0033/+91 20 3507 0000

Email:investors@emcure.com

URL:http://www.emcure.com

FAQs about Emcure Pharmaceuticals Ltd

1. What's the Emcure Pharmaceuticals Ltd share price today?
Emcure Pharmaceuticals Ltd share price was Rs 1,515.95 at close on 6th Feb 2026. Emcure Pharmaceuticals Ltd share price was up by 2.19% over the previous closing price of Rs 1,483.45. Emcure Pharmaceuticals Ltd share price trend:

  • Last 1 Month: Emcure Pharmaceuticals Ltd share price moved down by 0.71% on BSE.
  • Last 3 Months: Emcure Pharmaceuticals Ltd share price moved up by 14.36% on BSE.
  • Last 12 Months: Emcure Pharmaceuticals Ltd share price moved up by 17.86% on BSE.


2. How can I quickly analyse the performance of the Emcure Pharmaceuticals Ltd stock?
The performance of the Emcure Pharmaceuticals Ltd stock can be quickly analysed on the following metrics:

  • The stock's PE is 32.11
  • Price to book value ratio is 6.06
  • Dividend yield of 0.20
  • The EPS (trailing 12 months) of the Emcure Pharmaceuticals Ltd stock is Rs 47.20


3. What is the market cap of Emcure Pharmaceuticals Ltd?
Emcure Pharmaceuticals Ltd has a market capitalisation of Rs 28,738 crore.


4. What is Emcure Pharmaceuticals Ltd's 52-week high/low share price?
The Emcure Pharmaceuticals Ltd’s 52-week high share price is Rs 1,585.50 and 52-week low share price is Rs 890.00.


5. Is the Emcure Pharmaceuticals Ltd profitable?
On a consolidated basis, Emcure Pharmaceuticals Ltd reported a profit of Rs 231.37 crore on a total income of Rs 2,365.33 crore for the quarter ended 2025. For the year ended 2025, Emcure Pharmaceuticals Ltd had posted a profit of Rs 707.47 crore on a total income of Rs 7,896.00 crore.


6. Which are Emcure Pharmaceuticals Ltd’s peers in the Health care sector?
Emcure Pharmaceuticals Ltd’s top 5 peers in the Health care sector are Ajanta Pharma, Gland Pharma, J B Chemicals &, Emcure Pharma, Wockhardt, Astrazeneca Phar, Piramal Pharma.


7. Who owns how much in Emcure Pharmaceuticals Ltd?
Key changes to the Emcure Pharmaceuticals Ltd shareholding are as follows:

  • Promoter holding in Emcure Pharmaceuticals Ltd has gone down to 77.88 per cent as of Dec 2025 from 77.92 per cent as of Mar 2025.